Evidence map›Paper›PMID 30728266›Full record

ArticleJournal of virology2019

Broad Hemagglutinin-Specific Memory B Cell Expansion by Seasonal Influenza Virus Infection Reflects Early-Life Imprinting and Adaptation to the Infecting Virus.

Brenda L Tesini, Preshetha Kanagaiah, Jiong Wang, Megan Hahn, Jessica L Halliley, Francisco A Chaves, Phuong Q T Nguyen, Aitor Nogales, Marta L DeDiego, Christopher S Anderson and 13 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 57 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Preparedness, prevention and control related to zoonotic avian influenza.EFSA journal. European Food Safety Authority · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Original Antigenic Sin: How Original? How Sinful?Cold Spring Harbor perspectives in medicine · 2021
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 4 institutions in 1 country.

Brenda L Tesini *Division of Infectious Diseases, Department of Pediatrics, University of Rochester Medical Center, Rochester, New York, USA.ORCID 0000-0001-6051-0027
Preshetha Kanagaiah *David H. Smith Center for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA.
Jiong Wang *Division of Nephrology Department of Medicine, University of Rochester Medical Center, Rochester, New York, USA.
Megan HahnCenter for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
Jessica L HallileyDavid H. Smith Center for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA.
Francisco A ChavesDavid H. Smith Center for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA.
Phuong Q T NguyenDavid H. Smith Center for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA.
Aitor NogalesDepartment of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA.
Marta L DeDiegoDavid H. Smith Center for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA.
Christopher S AndersonDavid H. Smith Center for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA.ORCID 0000-0002-8560-3438
Ali H EllebedyDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.
Shirin StrohmeierDepartment of Microbiology, Icahn School of Medicine at Mt. Sinai, New York, New York, USA.
Florian KrammerDepartment of Microbiology, Icahn School of Medicine at Mt. Sinai, New York, New York, USA.ORCID 0000-0003-4121-776X
Hongmei YangDepartment of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, New York, USA.
Sanjukta BandyopadhyayDepartment of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, New York, USA.
Rafi AhmedDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.
John J TreanorDepartment of Medicine, University of Rochester Medical Center, Rochester, New York, USA.
Luis Martinez-SobridoDepartment of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA.
Hana GoldingCenter for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
Surender KhuranaCenter for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
Martin S ZandDivision of Nephrology Department of Medicine, University of Rochester Medical Center, Rochester, New York, USA.
David J TophamDavid H. Smith Center for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA.ORCID 0000-0002-9435-8673
Mark Y SangsterDavid H. Smith Center for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA mark_sangster@urmc.rochester.edu.
University of Rochester Medical Center · USCenter for Biologics Evaluation and Research · USEmory University · USIcahn School of Medicine at Mount Sinai · US

Funding

The University of Rochester's Clinical and Translational Science InstituteUL1TR002001 · NCATS · UNIVERSITY OF ROCHESTER · PI WILSON, KAREN M., ZAND, MARTIN S · 2016 to 2024
$34.6M
Understanding Human B Cell Responses to Influenza to Improve the Influenza U19AI109946 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI RAVETCH, JEFFREY VICTOR · 2014 to 2018
$9.6M
Modeling Mechanisms of Adjuvanted Influenza Vaccine Induced IgG Repertoire Diversity and Heterosubtypic ImmunityR01AI129518 · NIAID · UNIVERSITY OF ROCHESTER · PI HYRIEN, OLLIVIER, ZAND, MARTIN S · 2017 to 2021
$3.5M
Antibody responses in humans after infection with avian influenza virusesR01AI128821 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KRAMMER, FLORIAN · 2017 to 2021
$1.0M
Predictive Modeling of Multidimensional Anti-Influenza IgG RepertoiresR21AI138500 · NIAID · UNIVERSITY OF ROCHESTER · PI ZAND, MARTIN S · 2018 to 2019
$424k
NCATS NIH HHS UL1 TR002001NIAID NIH HHS HHSN272201200005CNIAID NIH HHS HHSN272201400005CNIAID NIH HHS HHSN272201400008CNIAID NIH HHS R01 AI128821NIAID NIH HHS R01 AI129518NIAID NIH HHS R21 AI138500NIAID NIH HHS U19 AI109946
6 · The paper itself

Abstract

Memory B cells (MBCs) are key determinants of the B cell response to influenza virus infection and vaccination, but the effect of different forms of influenza antigen exposure on MBC populations has received little attention. We analyzed peripheral blood mononuclear cells and plasma collected following human H3N2 influenza infection to investigate the relationship between hemagglutinin-specific antibody production and changes in the size and character of hemagglutinin-reactive MBC populations. Infection produced increased concentrations of plasma IgG reactive to the H3 head of the infecting virus, to the conserved stalk, and to a broad chronological range of H3s consistent with original antigenic sin responses. H3-reactive IgG MBC expansion after infection included reactivity to head and stalk domains. Notably, expansion of H3 head-reactive MBC populations was particularly broad and reflected original antigenic sin patterns of IgG production. Findings also suggest that early-life H3N2 infection "imprints" for strong H3 stalk-specific MBC expansion. Despite the breadth of MBC expansion, the MBC response included an increase in affinity for the H3 head of the infecting virus. Overall, our findings indicate that H3-reactive MBC expansion following H3N2 infection is consistent with maintenance of response patterns established early in life, but nevertheless includes MBC adaptation to the infecting virus.

Indexed as

Immunologic MemorySeasonsAntibodies, ViralB-LymphocytesHemagglutinin Glycoproteins, Influenza VirusHumansImmunoglobulin GInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeInfluenza, HumanAntibodies, ViralHemagglutinin Glycoproteins, Influenza Virushemagglutinin, human influenza A virusImmunoglobulin Ghemagglutininimprintinginfluenza virusmemory B cellsoriginal antigenic sin

Identifiers

PMID30728266
PMCPMC6450111
OpenAlexW2912098487

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.